A method that could lead to a safe and effective aerosol vaccine to prevent COVID-19 and to treat other respiratory infections has been identified by investigators at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School. “Targeted pulmonary delivery is needle-free and minimally invasive, an attribute particularly relevant in the administration of multi-dose vaccines or other molecules. Also, because the lungs are constantly being exposed to pathogens from the air, they have a high level of immune defense activity, and therefore may represent an efficient site for complete immune protection against airborne pathogens,” said co-corresponding author Wadih Arap, director of Rutgers Cancer Institute of New Jersey at University Hospital and chief of the Division of Hematology/Oncology at Rutgers New Jersey Medical School. To read the full story.